CAS RN: 581083-30-9
1H-Indazole-3-carboxylic acid, 4,5,6,7-tetrahydro-6,6-diMethyl-
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 581083-30-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
581083-30-9 / 6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxylic acid
Standard CAS: 581083-30-9
Multi CAS: No
Basic Information
copy
CAS
581083-30-9 copy
Multi CAS
No copy
Molecular Formula
C10H14N2O2 copy
Molecular Weight
194.230000 copy
Exact Mass
194.105528 copy
InChI
InChI=1S/C10H14N2O2/c1-10(2)4-3-6-7(5-10)11-12-8(6)9(13)14/h3-5H2,1-2H3,(H,11,12)(H,13,14) copy
InChIKey
OMXGCIRFKLMDNE-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
14 copy
Aromatic heavy atom count
5 copy
Fraction Csp3
0.6 copy
Rotatable bonds
1 copy
H-bond acceptors
2 copy
H-bond donors
2 copy
Molar refractivity
51.35 copy
TPSA
65.98 copy
LogP / Solubility
WLOGP
1.62 copy
MLOGP
1.43 copy
XLogP3
2.1 copy
Consensus LogP
1.72 copy
Log S (ESOL)
-2.26 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.32 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.39 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.75 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy